Invivyd, Inc. (IVVD)
0.6636
+0.06
(+9.18%)
USD |
NASDAQ |
Oct 15, 16:00
0.679
+0.02
(+2.32%)
After-Hours: 20:00
Invivyd Gross Profit Margin (Quarterly) : 86.62% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 86.62% |
| March 31, 2026 | 88.76% |
| December 31, 2025 | 90.85% |
| September 30, 2025 | 88.43% |
| June 30, 2025 | 89.92% |
| Date | Value |
|---|---|
| March 31, 2025 | 86.09% |
| December 31, 2024 | 83.79% |
| September 30, 2024 | 85.32% |
| June 30, 2024 | 73.41% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.47% |
| Return on Assets | -55.57% |
| Return on Invested Capital | -68.22% |
| Profit Margin (Quarterly) | -310.8% |
| Operating Margin (Quarterly) | -320.8% |
| Return on Net Operating Assets | -402.7% |